Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

Daiichi pulls study of patritumab in lung cancer

Daiichi pulls study of patritumab in lung cancer The two-stage trial of patritumab (U3-1287/AMG 888) in combination with Roche's EGFR inhibitor Tarceva (erlotinib) patients with non-small cell lung cancer (NSCLC) was stopped on the

FDA approves expanded indication for Gilotrif

FDA approves expanded indication for Gilotrif It showed Gilotrif achieved its primary objective of significantly improving progression-free survival when compared against Roche/Astellas' Tarceva (erlotinib).

FDA panel says no to quick approval of Clovis' rociletinib

FDA panel says no to quick approval of Clovis' rociletinib The drug is a third-generation EGFR inhibitor designed for use when other drugs in the class - Roche/Astellas' market-leading Tarceva (erlotinib), AstraZeneca's Iressa (gefitinib) and Boehringer Ingelheim's

Boehringer's Giotrif wins new NSCLC licence in Europe

Boehringer's Giotrif wins new NSCLC licence in Europe Giotrif reached its primary endpoint in the study of significantly delaying the progression of SqCC of the lung when compared against Roche/Astellas' Tarceva (erlotinib). ... year. Giotrif joins several EGFR-targeting therapies on the market, including

Japanese approvals for GSK, AZ and Bayer

Japanese approvals for GSK, AZ and Bayer The drug has been cleared for use in patients who have developed resistance to other EGFR inhibitors such as Roche/Astellas' Tarceva (erlotinib), AZ's Iressa (gefitinib) and Boehringer Ingelheim's

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics